• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Baxter International (NY: BAX )

    29.50 +0.60 (+2.08%)
    Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Baxter International

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    “Healthcare Left For Dead” Stock Market (And Sentiment Results)
    This afternoon felt like either a fund blew up or the margin clerks were taking a bunch of dumb over-leveraged money out to the woodshed to put them out of their misery. 
    Via Talk Markets
    Topics Stocks / Equities
    Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
    Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
    Via Benzinga
    Baxter International: Dividend Cut Because Of Restructuring
    Baxter International (BAX) cut its dividend because of the upcoming sale of the Kidney Care business, high debt and leverage, lower earnings per share, and free cash flow. 
    Via Talk Markets
    Topics Stocks / Equities
    Baxter Expects Hurricane Helene Aftermath To Impact Near-Term Financial Outlook
    Baxter International's Q3 2024 adjusted EPS of $0.80 beat estimates, driven by strong Medical Products & Therapies sales and improved supply chain management. 
    Via Benzinga
    Topics Economy
    Exposures Supply Chain
    Uncovering Potential: Baxter Intl's Earnings Preview
    Via Benzinga
    3 Shareholder Yield Stocks For Growth And Dividends
    Top shareholder yield stocks are generating returns by paying dividends, buying back stock, and reducing debt. 
    Via Talk Markets
    Beyond The Numbers: 6 Analysts Discuss Baxter Intl Stock
    Via Benzinga
    “Jackets And Packets” Stock Market (And Sentiment Results)
    Revenues continue to grow, Free Cash Flow recovering, Margins high, Stock Price subdued. 
    Via Talk Markets
    US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene
    The U.S. faces a critical shortage of IV fluids due to Hurricane Helene's damage to Baxter's North Carolina plant, forcing hospitals to delay surgeries. Federal efforts to rebuild and import supplies... 
    Via Benzinga
    Baxter's North Carolina Plant Recovery Underway After Hurricane Flooding, Starts Product Imports
    Baxter International resumes IV fluid shipments from international sites after Hurricane Helene disrupted production at its North Carolina plant, which supplies 60% of U.S. IV fluids. FDA approves... 
    Via Benzinga
    Exposures Product Safety
    Baxter's North Carolina Facility Manufactures ~60% Of IV Fluids And Peritoneal Dialysis Solutions, Senator Demands Immediate Action To Protect Patient Care Amid Shortage
    U.S. Senator Amy Klobuchar has called on HHS Secretary Xavier Becerra to address the national IV solution shortage following the closure of Baxter's facility due to Hurricane Helene, which compromises... 
    Via Benzinga
    Hurricane Helene Economic Price Tag Could Be $34 Billion; The Stock Market Impact
    Moody's Analytics projects major costs. 
    Via Investor's Business Daily
    Hurricane Helene Shutters Baxter International's Key Manufacturing Hub In North Carolina
    Baxter International shuts down its largest manufacturing facility in North Carolina due to Hurricane Helene's damage. Shares fall. 
    Via Benzinga
    The Latest Analyst Ratings For Baxter Intl
    Via Benzinga
    Assessing Baxter Intl: Insights From 4 Financial Analysts
    Via Benzinga
    How Is The Market Feeling About Baxter Intl?
    Via Benzinga
    Medtronic Inc. Dividend Stock Analysis - Sunday, Sept. 29
    Medtronic Inc. is a global medical device manufacturer with leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management, and other medical markets. Here are some highlights... 
    Via Talk Markets
    Medtronic Recalls Some Video Laryngoscopes Due To Increased Risk For Battery Overheat, Explosion
    Medtronic recalls devices over battery risks that could lead to explosions and updates usage instructions. 
    Via Benzinga
    Topics Product Recall
    Exposures Legal Product Safety
    Rivian, Chipotle Mexican And Sirius XM Are Among Top 10 Large Cap Losers Last Week (Aug 11-Aug 17): Are The Others In Your Portfolio?
    Ten large-cap stocks were the worst performers last week, with TME, MBLY, RIVN, CMG, LINE, SIRI, HSY, BAX, BR, and UTHR all seeing declines. 
    Via Benzinga
    Baxter Tumbles On $3.8 Billion Kidney Deal — Why Investors Expected More
    The company is selling its Vantive Kidney Care business to Carlyle, a private equity investor in the medtech space. 
    Via Investor's Business Daily
    Baxter Seals $3.8B Deal With Carlyle For Its Kidney Care Segment
    Baxter has agreed to sell its Kidney Care segment to Carlyle for $3.8 billion. Baxter will receive about $3.5 billion in cash, with net after-tax proceeds estimated at $3 billion. Post-sale, Baxter... 
    Via Benzinga
    BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q2 2024
    BAX stock results show that Baxter Intl beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Baxter Lifts Annual Outlook After Strong Q2 Beat, Medical Devices Sales
    Baxter surpasses Q2 expectations with adjusted EPS of $0.68 and sales of $3.812 billion. Sales rose 3% reported and 4% constant currency, driven by Pharmaceuticals, Medical Products, and Healthcare... 
    Via Benzinga
    3 Contrarian Stock Picks to Buy Against the Market Consensus
    Discover three contrarian stock picks with strong fundamentals that defy current market trends and offer significant rebound potential. 
    Via InvestorPlace
    Carlyle's $4B Purchase Of Baxter's Kidney Division Backed By Ares And HPS Financing
    Ares Management and HPS Investment Partners lead a $3 billion credit facility to support Carlyle's potential acquisition of Baxter's kidney-care division, highlighting the evolving role of private... 
    Via Benzinga
    AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    3 Bargain Bin Stocks with Millionaire-Maker Potential
    Three bargain stocks with substantial upside from potential price-to-earnings multiple reratings and accretive buybacks. 
    Via InvestorPlace
    Carlyle Eyes $4B Acquisition Of Baxter's Kidney-Care Unit Vantive: Report
    Carlyle is negotiating to acquire Baxter International's kidney-care spinoff, Vantive, in a $4 billion deal, including debt. The deal reflects a significant move in private-equity dealmaking and... 
    Via Benzinga
    “Cash Flow Is The Name Of The Game” Stock Market
    Liquidity is becoming a problem and the Fed (and other Central Bankers) know it. Higher for longer is a luxury they can no longer afford. 
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.